ENANTA PHARMACEUTICALS INC (ENTA) Form 10-K Annual Reports
ENANTA PHARMACEUTICALS INC (ENTA) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: ENTA
CIK: 1177648
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 09/30
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
PricewaterhouseCoopers LLP
Auditor SinceSince 9/30/2017 12:00:00 AM
Lead Engagement PartnerFrancis Loftus
Audit LocationBoston, Massachusetts, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| SCHEDULE 13G/A | 2026-08-14 | — | SCHEDULE 13G/A Filing | 0001172661-26-003479 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-14 | — | SCHEDULE 13G/A Filing | 0000908834-26-000416 | View SEC Doc Filr Page |
| 10-Q | 2026-08-12 | 2026-06-30 | 10-Q | 0001193125-26-345719 | View SEC Doc Filr Page |
| 8-K | 2026-08-10 | 2026-08-10 | 8-K | 0001193125-26-342336 | View SEC Doc Filr Page |
| 4 | 2026-08-10 | 2026-08-08 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0002064832-26-000266 | View SEC Doc Filr Page |
| 8-K | 2026-07-02 | 2026-07-02 | 8-K | 0001193125-26-294837 | View SEC Doc Filr Page |
| 424B5 | 2026-07-02 | — | 424B5 | 0001193125-26-294828 | View SEC Doc Filr Page |
| 8-K | 2026-06-23 | 2026-06-23 | 8-K | 0001193125-26-279803 | View SEC Doc Filr Page |
| 8-K | 2026-06-18 | 2026-06-18 | 8-K | 0001193125-26-274950 | View SEC Doc Filr Page |
| S-8 | 2026-05-13 | — | S-8 | 0001193125-26-220600 | View SEC Doc Filr Page |
| 10-Q | 2026-05-13 | 2026-03-31 | 10-Q | 0001193125-26-220572 | View SEC Doc Filr Page |
| 8-K | 2026-05-11 | 2026-05-11 | 8-K | 0001193125-26-216735 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-03-26 | — | SCHEDULE 13G/A Filing | 0000102909-26-001192 | View SEC Doc Filr Page |
| 8-K | 2026-03-26 | 2026-03-20 | 8-K | 0001193125-26-125113 | View SEC Doc Filr Page |
| 4 | 2026-03-13 | 2026-03-11 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0002064832-26-000143 | View SEC Doc Filr Page |
| 4 | 2026-03-13 | 2026-03-11 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0002064832-26-000142 | View SEC Doc Filr Page |
| 4 | 2026-03-13 | 2026-03-11 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0002064832-26-000141 | View SEC Doc Filr Page |
| 4 | 2026-03-13 | 2026-03-11 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0002064832-26-000140 | View SEC Doc Filr Page |
| 4 | 2026-03-13 | 2026-03-11 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0002064832-26-000139 | View SEC Doc Filr Page |
| 4 | 2026-03-13 | 2026-03-11 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0002064832-26-000138 | View SEC Doc Filr Page |
| 8-K | 2026-03-12 | 2026-03-11 | 8-K | 0001193125-26-104109 | View SEC Doc Filr Page |
| EFFECT | 2026-02-20 | — | EFFECT Filing | 9999999995-26-000642 | View SEC Doc Filr Page |
| CORRESP | 2026-02-17 | — | CORRESP Filing | 0001193125-26-055328 | View SEC Doc Filr Page |
| UPLOAD | 2026-02-17 | — | UPLOAD Filing | 0000000000-26-001607 | View SEC Doc Filr Page |
| 4 | 2026-02-13 | 2026-02-12 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0002064832-26-000016 | View SEC Doc Filr Page |